Teleflex Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex or view top-rated stocks.

Wall Street analysts have given Teleflex a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teleflex wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Teleflex saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 520,900 shares, a decrease of 38.7% from the August 15th total of 849,200 shares. Based on an average trading volume of 335,800 shares, the short-interest ratio is presently 1.6 days. Currently, 1.1% of the shares of the company are short sold.
View Teleflex's Short Interest.

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Teleflex.

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings results on Thursday, July, 29th. The medical technology company reported $3.35 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.87 by $0.48. The medical technology company had revenue of $713.47 million for the quarter, compared to analysts' expectations of $680.85 million. Teleflex had a net margin of 13.06% and a trailing twelve-month return on equity of 17.29%. During the same period last year, the firm posted $1.93 EPS.
View Teleflex's earnings history.

Teleflex's stock was trading at $342.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TFX stock has increased by 12.8% and is now trading at $385.97.
View which stocks have been most impacted by COVID-19.

Teleflex declared a quarterly dividend on Thursday, July 29th. Shareholders of record on Monday, August 16th will be given a dividend of $0.34 per share on Wednesday, September 15th. This represents a $1.36 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Friday, August 13th.
View Teleflex's dividend history.

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.35%. The dividend payout ratio of Teleflex is 12.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.32% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

Teleflex issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $12.900-$13.100 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.750. The company issued revenue guidance of $2.80 billion-$2.84 billion, compared to the consensus revenue estimate of $2.82 billion.

10 brokerages have issued 12-month target prices for Teleflex's stock. Their forecasts range from $415.00 to $486.00. On average, they anticipate Teleflex's share price to reach $455.80 in the next twelve months. This suggests a possible upside of 18.1% from the stock's current price.
View analysts' price targets for Teleflex or view top-rated stocks among Wall Street analysts.

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

Some companies that are related to Teleflex include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Baxter International (BAX), STERIS (STE), Insulet (PODD), Hologic (HOLX) and Abiomed (ABMD).
View all of TFX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (12.12%), Vanguard Group Inc. (10.62%), BlackRock Inc. (10.54%), State Street Corp (3.99%), American Century Companies Inc. (2.81%) and Marshall Wace LLP (1.96%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends for Teleflex.

TFX stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Mar Vista Investment Partners LLC, BlackRock Inc., APG Asset Management N.V., Atlanta Capital Management Co. L L C, Nuveen Asset Management LLC, William Blair Investment Management LLC, and Invesco Ltd.. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, and Stuart A Randle.
View insider buying and selling activity for Teleflex or view top insider-selling stocks.

TFX stock was bought by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, FMR LLC, JPMorgan Chase & Co., Amundi, Marshall Wace LLP, Citadel Advisors LLC, Kimelman & Baird LLC, and Woodline Partners LP.
View insider buying and selling activity for Teleflex or or view top insider-buying stocks.

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TFX stock can currently be purchased for approximately $385.97.

Teleflex has a market capitalization of $18.06 billion and generates $2.54 billion in revenue each year. The medical technology company earns $335.32 million in net income (profit) each year or $10.67 on an earnings per share basis.

Teleflex employs 14,000 workers across the globe.

Teleflex was founded in 1943.

The official website for Teleflex is www.teleflex.com.

Teleflex is headquartered at 550 E SWEDESFORD RD, WAYNE PA, 19087.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at (610) 225-6800 or via email at [email protected]